Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Extended-Interval Aminoglycoside Dosing (Hartford Nomogram) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Extended-Interval Aminoglycoside Dosing (Hartford Nomogram)?
The Extended-Interval Aminoglycoside Dosing (Hartford Nomogram) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in pharmacology & toxicology practice. Implements the Hartford Hospital Extended-Interval Aminoglycoside Dosing Nomogram, optimizing concentration-dependent bactericidal killing (Cmax/MIC ≥ 10) while minimizing nephrotoxicity and ototoxicity via prolonged drug-free post-antibiotic effect intervals. Clinical scoring tools like Extended-Interval Aminoglycoside Dosing (Hartford Nomogram) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Capitalizes on the post-antibiotic effect (PAE) and concentration-dependent killing of Gram-negative pathogens (e.g. Pseudomonas) while drastically reducing renal accumulation.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Extended-Interval Aminoglycoside Dosing (Hartford Nomogram):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 500 | Standard Dose Range | green |
| ≥ 501 | High-Dose Range | yellow |
When to Exercise Caution
Not validated for synergistic enterococcal endocarditis (requires traditional low-dose 1 mg/kg TID dosing) or in end-stage renal disease / dialysis.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •Nicolau DP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39(3):650-655.
- •Freeman CD, et al. Once-daily aminoglycosides: review and recommendations. J Antimicrob Chemother. 1997;39(6):677-686.
Related Pharmacology & Toxicology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Pharmacology & Toxicology:
Body Surface Area (BSA)
Calculate BSA using the Mosteller formula.
Ideal Body Weight (IBW)
Calculate ideal body weight using the Devine formula.
Creatinine Clearance (Cockcroft-Gault)
Estimates renal function for drug dosing using the Cockcroft-Gault equation.
Corrected QT (QTc)
Calculates the QTc interval using Bazett's formula.
SOFA Score
Sequential Organ Failure Assessment score for predicting ICU mortality.
Parkland Formula for Burns
Calculates fluid resuscitation requirements for burn patients.